EV Biologics, Inc. (YECO)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.28 Million | -20.84 Million | 697.91 Thousand | 97.68 Thousand | 1.54 Million | 13.27 Million |
| Net Income | -1.26 Million | -21.05 Million | -387.69 Thousand | -98.96 Thousand | -551.58 Thousand | -53.19 Million |
| Depreciation & Amortization | - | - | - | - | 686.99 Thousand | 2.21 Million |
| Deferred income taxes | - | - | - | - | 225.58 Thousand | 92.18 Thousand |
| Stock-based compensation | - | - | - | - | 162.36 Thousand | 534.23 Thousand |
| Change in working capital | -2.01 Million | 213.78 Thousand | 1.08 Million | 196.64 Thousand | 4.05 Million | 4.41 Million |
| Other non-cash items | 117.59 Thousand | -75.72 Thousand | 118.9 Thousand | - | -3.03 Million | 59.2 Million |
| Investing Cash Flow | 10.79 Million | 19.78 Million | -21.67 Million | - | -1.92 Million | -36.6 Million |
| Investments in PPE | -39.43 Thousand | - | -19.26 Million | - | -1.92 Million | -36.62 Million |
| Acquisitions | - | 6.93 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 10.83 Million | 12.84 Million | -2.41 Million | - | - | 20.46 Thousand |
| Financing Cash Flow | -7.72 Million | 1.99 Million | 21.68 Million | 4814.00 | -450.64 Thousand | 10.62 Million |
| Debt repayment | -21.18 Million | -999.97 Thousand | -21.68 Million | - | -17.47 Thousand | -6.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 4814.00 | - | 11.51 Million |
| Other Financing Activities | 13.45 Million | 992.57 Thousand | - | - | -433.16 Thousand | 5.61 Million |
| Accounts receivables | -15.31 Thousand | -131.1 Thousand | -118.9 Thousand | - | -1.35 Million | -1.12 Million |
| Accounts payables | -102.28 Thousand | 206.82 Thousand | - | - | 623.8 Thousand | 127.93 Thousand |
| Inventory | - | - | - | - | 147.65 Thousand | -30.98 Thousand |
| Other working capital | -1.89 Million | 138.05 Thousand | 2.29 Million | 196.64 Thousand | 4.63 Million | 5.44 Million |
| Cash at beginning of period | 335.07 Thousand | 600 Thousand | 102.5 Thousand | - | 2.73 Million | 16.47 Million |
| Cash at end of period | 126.78 Thousand | 335.07 Thousand | 600 Thousand | 102.5 Thousand | 1.81 Million | 2.73 Million |
| Capital Expenditure | -39.43 Thousand | - | -19.26 Million | - | -1.92 Million | -36.62 Million |
| Effect of forex changes on cash | - | -1.2 Million | -205 Thousand | - | -90.86 Thousand | -1.03 Million |
| Net cash flow / Change in cash | -208.29 Thousand | -264.92 Thousand | 497.5 Thousand | 102.5 Thousand | -920.63 Thousand | -13.73 Million |
| Free Cash Flow | -3.32 Million | -20.84 Million | -18.56 Million | 97.68 Thousand | -379.11 Thousand | -23.34 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.42 Thousand | -191.54 Thousand | -197.69 Thousand | -1.26 Million | -235.7 Thousand | -377.91 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -83.88 Thousand | 172.53 Thousand | 91.56 Thousand | -2.01 Million | 20.38 Million | -22.64 Million |
| Other non-cash items | -4820.59 | -3220.30 | -2354.00 | 117.59 Thousand | 212.71 Thousand | -161.67 Thousand |
| Investing Cash Flow | - | - | - | 10.79 Million | 106.25 Thousand | -183.65 Thousand |
| Investments in PPE | 1.00 | 3.55 | - | -39.43 Thousand | -255.59 | 689.83 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 10.83 Million | 106.51 Thousand | -184.34 Thousand |
| Financing Cash Flow | -1994.65 | 1721.65 | - | -7.72 Million | -20.62 Million | 23.75 Million |
| Debt repayment | -1994.65 | -1721.65 | - | -21.18 Million | -20.76 Million | -21.4 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 13.45 Million | 132.25 Thousand | 2.35 Million |
| Accounts receivables | 51.66 | 4651.15 | 2354.00 | -15.31 Thousand | -218.17 Thousand | -43.66 Thousand |
| Accounts payables | - | - | - | -102.28 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -83.94 Thousand | 167.88 Thousand | 89.2 Thousand | -1.89 Million | 20.7 Million | -22.59 Million |
| Cash at beginning of period | 4337.00 | 20.64 Thousand | 126.78 Thousand | 335.07 Thousand | 511.84 Thousand | 155.91 Thousand |
| Cash at end of period | -23.00 | 4337.00 | 20.64 Thousand | 126.78 Thousand | 126.78 Thousand | 511.84 Thousand |
| Capital Expenditure | 1.00 | 3.55 | - | -39.43 Thousand | -255.59 | 689.83 |
| Effect of forex changes on cash | - | - | - | - | -9387.00 | 7522.00 |
| Net cash flow / Change in cash | -4360.00 | -16.31 Thousand | -106.13 Thousand | -208.29 Thousand | -385.06 Thousand | 355.93 Thousand |
| Free Cash Flow | -3280.00 | -17.57 Thousand | -106.13 Thousand | -3.32 Million | 20.14 Million | -23.22 Million |
PLNTQ
7832
RATO-A
EIX
PEP
000599